Canaccord Genuity Assumes Coverage on Magnum Hunter (MHR) at Buy; Sum of Parts Warranted Given Relative Mispricing of Assets
Tweet
Share
E-mailGet Alerts MHR Hot Sheet
Price: $0.15 --0%
Rating Summary:
4 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity assumes coverage on Magnum Hunter (NYSE: MHR) with a Buy. PT lowered by $1 to $9.
Canaccord analyst, Marcus Talbert, said, "We assume coverage of Magnum Hunter Resources, maintaining a BUY rating with a revised $9 target. At present, we believe the market does not fully appreciate MHR’s rich opportunity set, and we believe the stock is too cheap for a company with its asset base and relative growth potential. In our view, the stock is well positioned to outperform based on its leading exposure to liquids-rich trends and material catalysts (Eagle Ford wells, additional bolt-on deals and asset divestures)."
For more ratings news on Magnum Hunter click here and for the rating history of Magnum Hunter click here.
Shares of Magnum Hunter closed at $4.62 yesterday.
Canaccord analyst, Marcus Talbert, said, "We assume coverage of Magnum Hunter Resources, maintaining a BUY rating with a revised $9 target. At present, we believe the market does not fully appreciate MHR’s rich opportunity set, and we believe the stock is too cheap for a company with its asset base and relative growth potential. In our view, the stock is well positioned to outperform based on its leading exposure to liquids-rich trends and material catalysts (Eagle Ford wells, additional bolt-on deals and asset divestures)."
For more ratings news on Magnum Hunter click here and for the rating history of Magnum Hunter click here.
Shares of Magnum Hunter closed at $4.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- Wells Fargo Starts Vivmark Residential (VMRK) at Overweight, 'Setting the mark for growth'
- DA Davidson Starts Everus (ECG) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
